Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,933,953
-
Share change
-
-549,550
-
Total reported value
-
$2,513,200
-
Price per share
-
$1.30
-
Number of holders
-
16
-
Value change
-
-$782,100
-
Number of buys
-
6
-
Number of sells
-
8
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q2 2019
As of 30 Jun 2019,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,933,953 shares.
The largest 10 holders included
CVI Holdings, LLC, MORGAN STANLEY, SABBY MANAGEMENT, LLC, MACQUARIE GROUP LTD, RAYMOND JAMES & ASSOCIATES, LADENBURG THALMANN FINANCIAL SERVICES INC., ATHENA CAPITAL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, and Menta Capital LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.